Questioning Medicine
Questioning Medicine
Join Andrew on a medical rollercoaster as we ask a medical question and answer it based on recent published papers.
N'hésitez pas à visiter le site du podcast et à soutenir son créateur : www.podomatic.com
Auteur
Questioning Medicine
Catégorie
Site du podcast
Dernier épisode
21 oct. 2026
Où écouter ?
Les podcasts dans l'appli Replaio Radio Bientôt disponibleLes podcasts arrivent très bientôt dans l'appli. Installe-la dès maintenant et découvre en avant-première une toute nouvelle façon de vivre les podcasts
Épisodes
Episode 389: 400. CRP, Lipoprotein A, LDL for cardiac risk assessment 29.05.2025 9:37
https://www.nejm.org/doi/full/10.1056/NEJMoa2405182?query=recirc_Semantic Key Takeaways Extended Predictive Value of Biomarkers : High-sensitivity C-reactive protein (CRP), LDL cholesterol, and lipoprotein(a) levels were found to be predictive of cardiovascular events over a 30-year period. These markers contribute independently to long-term cardiovascular risk beyond traditional 10-year risk...
Episode 388: 399. Use of albumin-adjusted calcium measurements in clinical practice 27.05.2025 7:48
Desgagnés N et al. Use of albumin-adjusted calcium measurements in clinical practice. JAMA Netw Open 2025 Jan 21; 8:e2455251. ( https://doi.org/10.1001/jamanetworkopen.2024.55251 ) Overall, total calcium levels (just the ones we would get back on a basic cmp) correlated better with ionized calcium than did formula-corrected calcium levels. Formulas with stronger correlation than total calcium leve...
Episode 387: 398. Which is Better, Tirzepatide or Semaglutide? 21.05.2025 8:38
https://www.nejm.org/doi/10.1056/NEJMoa2416394 At 72 weeks, the mean percentage decrease in weight was significantly greater with tirzepatide than with semaglutide (20% vs. 14%). Gastrointestinal side effects occurred frequently in both groups but led to discontinuation of treatment in only 3% and 6% of participants in the tirzepatide and semaglutide groups, respectively. Injection-site reactions...
Episode 386: 397. What is the new drug for smoking cessation? 09.05.2025 5:25
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2832701 In this multisite trial, 800 adults who smoked 10 or more cigarettes daily (mean duration of smoking, ≈35 years) were randomized to 6 or 12 weeks of cytisinicline or to placebo. In the 6-week group,15% of cytisinicline recipients and 6% of placebo recipients were abstinent (defined by self-report and breath carbon monoxide &...
Episode 385: 396. Vitamin D and Kids (CME) 07.05.2025 8:56
What does the evidence and the guidelines say about the use and testing of Vitamin D in kids
Episode 384: 395. How accurate is the BMI? 06.05.2025 5:18
Aryee EK et al. Prevalence of obesity with and without confirmation of excess adiposity among US adults. JAMA 2025 Apr 17; [e-pub]. ( https://doi.org/10.1001/jama.2025.2704 ) The rate of obesity was 39.7% based on BMI and 39.1% based on excess adiposity. Among participants with obesity based on BMI, 98% also had excess adiposity; in other words, essentially the same individuals were considered as...
Episode 383: 394. Does the time of day effect bronchodilator responsiveness? 02.05.2025 7:28
In an hour-by-hour analysis, patients we suspect to have asthma are significantly more likely to have positive bronchodilator responses early in the morning; with each passing hour before testing, there was small decrease (8%) in positive response. Patients also were more likely to have positive responses in the winter. Knox-Brown B et al. Effect of time of day and seasonal variation on bronchodi...
Episode 382: 393. CME-- Vitamin D and Adults 01.05.2025 38:43
Vitamin D and Adults and what you should do with Vitamin D
Episode 381: 392. Outpatient Management of COPD - CME 21.04.2025 36:42
a cme lecture on the outpatient management of COPD
Episode 380: 391. Hospital Medicine Electrolyte Abnormalities - CME 05.04.2025 43:10
CME
Episode 379: 390. Hospital Medicine- AKI CME 04.04.2025 38:54
FREE CME KNOWLEDGE
Episode 378: 389. Stroke- Admit to Discharge. CME 19.03.2025 42:14
Free CME
Episode 377: 388. ACOI COPD and PNA 19.03.2025 37:43
CME for FREE
Episode 376: 387. Methods Monday and an Example of Subgroup Analysis 17.03.2025 8:31
https://www.nejm.org/doi/full/10.1056/NEJMoa2405923?query=clinical-medicine Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is beneficial after myocardial infarction is uncertain. Recent attempts to improve outcomes with intensified renin–angiotensin–aldoste...
Episode 375: 386. Could half dose anticoagulation be the answer? 14.03.2025 8:12
Estimated 5-year incidence of recurrent VTE was similar in the reduced-dose and full-dose groups (2.2% and 1.8%). Estimated 5-year bleeding incidence was significantly lower with reduced-dose than with full-dose treatment (2.1% vs. 4.0% for major bleeding; 8.6% vs. 11.5% for clinically relevant nonmajor bleeding). Outcomes with apixaban and rivaroxaban were similar. Couturaud F et al. Extended tre...
Episode 374: 385. PRACTICE CHANGER! Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis 12.03.2025 6:34
https://www.nejm.org/doi/full/10.1056/NEJMoa2405404 NNT of 4! systemic metronid and topical clinda bid for one week
Episode 373: 384. Chronic Kidney Disease and Empagliflozin Legacy Effect 11.03.2025 9:11
What Was Studied? The EMPA-KIDNEY trial followed 6,609 CKD patients at risk of disease progression. Participants were randomly assigned to receive empagliflozin (10 mg daily) or a placebo for a median of 2 years. After this ‘active’ phase, 4,891 patients entered a 2-year post-trial observational period where neither group received the trial drug, but doctors could prescribe open-label SGLT2 inhibi...
Episode 372: 383. What is the GFR at which we stop metforin? 06.03.2025 10:58
Metformin while not necessarily first line therapy for diabetes depending on the patients co-morbid conditions it is certainly highly ranked on the list of medications! I know often metformin is stopped while coming into the hospital for fear of potentially lactic acidosis or an increase in AKI with contrast studies however this ‘belief’ is largely based on myth and misconception. Metformin's co...
Episode 371: 382. Is it safe to give the flu and covid vaccine at the same time? 04.03.2025 7:18
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825813 Conclusions and Relevance In this randomized clinical trial assessing simultaneous vs sequential administration of mRNA COVID-19 and IIV4 vaccines, reactogenicity was comparable in both groups. These findings support the option of simultaneous administration of these vaccines.
Episode 370: 381. Relative efficacy of prehabilitation interventions and their components 27.02.2025 7:08
https://www.bmj.com/content/388/bmj-2024-081164 systematic review and meta-analysis on prehabilitation before surgery, published in the BMJ in February 2025.Prehabilitation aims to prepare patients for surgery through interventions like exercise, nutrition, and psychological support. This study looked at which prehabilitation components are most effective for improving key outcomes after surgery....
Episode 369: 380. REPOST mammo part 2 24.02.2025 20:33
Mammograms
Episode 368: 379. REPOST mammogram part 1 18.02.2025 19:26
379. REPORT mammogram part 1
Episode 367: 378. What is the Best Way To Treat Ductal Carcinoma In Situ 12.02.2025 8:26
https://jamanetwork.com/journals/jama/article-abstract/2828218 DCIS is a non-invasive form of breast cancer, meaning the abnormal cells are contained within the milk ducts. For years, the standard treatment has been surgery, often followed by radiation and/or hormone therapy - the same treatments used for invasive breast cancer. But is this aggressive approach always necessary for low-risk DCIS? (...
Episode 366: 377. Does How Long You Have Hypertension Matter? 11.02.2025 7:22
Association of Duration of Recognized Hypertension and Stroke Risk: The REGARDS Study (Transition Music - Short and subtle - 2 seconds)Host: Hypertension is a well-known risk factor for stroke, but this study, led by Dr. George Howard and colleagues, asks a fascinating question: Does the duration of hypertension matter, even when blood pressure is managed? (Transition Music - Short and...
Episode 365: 366. Association of dose of inhaled corticosteroids and frequency of adverse events 07.02.2025 6:07
Bloom CI et al. Association of dose of inhaled corticosteroids and frequency of adverse events. Am J Respir Crit Care Med 2025 Jan; 211:54. ( https://doi.org/10.1164/rccm.202402-0368OC ) Bloom and colleagues' study, published in the American Journal of Respiratory and Critical Care Medicine in January 2025, provides significant insights into the safety profile of inhaled corticosteroids (ICS)...
Podcasts similaires
Replaio n'est pas éditeur de podcasts ; les noms des émissions, les visuels et l'audio appartiennent à leurs auteurs et sont diffusés via des flux RSS publics